HomeInsights52 Week Low Stocks

Piramal Pharma Ltd 52 Week Low

Piramal Pharma Ltd 52 Week Low

stocks purchased

₹ 6.2 Cr

Volume Transacted

(Nov 22, 2024)

stocks purchased

246.9 K

Stocks Traded

(Nov 22, 2024)

Last Updated on: Nov 23, 2024

Image

Piramal Pharma Ltd

NSE: PPLPHARMA

YEARLOW

₹ 114.45

Last updated on: Nov 22, 2024

Key Highlights

  • The 52 Week Low of Piramal Pharma Ltd is ₹ 114.45 as of 22 Nov 24 .

Company Fundamentals for Piramal Pharma Ltd

No data available

Market Price of Piramal Pharma Ltd

1M

1Y

3Y

5Y

Monitoring Piramal Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
22 Nov 2024249.9
21 Nov 2024245.95
19 Nov 2024250.8
18 Nov 2024251.95
14 Nov 2024258.4
13 Nov 2024259.7
12 Nov 2024250.55
11 Nov 2024269.65
08 Nov 2024281.8
07 Nov 2024292.1

Asset Value vs Market Value of Piramal Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Piramal Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Piramal Pharma Ltd

No data available

* All values are in crore

Piramal Pharma Ltd News Hub

News

Piramal Pharma hits life high on reporting multi-fold jump in Q2 PAT

Revenue from operations grew by 17.28% year on year (YoY) to Rs 2,241.75 crore during the ...

Read more

24 Oct 202412:32

News

Piramal Pharma to declare Quarterly Result

Piramal Pharma will hold a meeting of the Board of Directors of the Company on 23 October ...

Read more

15 Oct 202410:20

News

Piramal Pharma to invest $80M to expand its Lexington, Kentucky facility

Piramal Pharma Solutions (PPS), a leading global Contract Development and Manufacturing Or...

Read more

30 Sep 202418:48

News

Piramal Pharma receives SBTi validation for its GHG commitment

Piramal Pharma has embarked on its sustainability journey as the Science Based Targets ini...

Read more

17 Sep 202410:14

News

Piramal Pharma grants 48.30 lakh stock options

Piramal Pharma has granted 48,30,836 stock options under Employee Stock Option and Incenti...

Read more

26 Jul 202410:05

News

Piramal Pharma Q1 net loss narrows to Rs 89 crore

Revenue from operations grew by 11.57% year on year (YoY) to Rs 1,951.14 crore during the ...

Read more

26 Jul 202414:28

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week Low of Piramal Pharma Ltd

Why is it important to track the 52-week low of Piramal Pharma Ltd stocks?

Investors should monitor the 52-week low of Piramal Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time. Frequent monitoring will help traders identify trends and make timely decisions.

What factors can lead to Piramal Pharma Ltd stocks hitting a 52-week low?

Factors leading to Piramal Pharma Ltd stocks hitting a 52-week low may include poor fiscal results, negative industry trends, macroeconomic issues, or management changes. Other factors such as market volatility and broader economic downturns can also contribute to a 52-week low.

Should investors buy Piramal Pharma Ltd stocks when they hit a 52-week low?

Buying Piramal Pharma Ltd stocks at a 52-week low can offer a potential bargain, however, it is crucial to evaluate the reasons behind the stock price drop and ensure there is no underlying fundamental issue. Investors should consider the company's long-term prospects before making a buying decision.

How often should investors monitor the 52-week low of Piramal Pharma Ltd stocks?

Investors should monitor the 52-week low of Piramal Pharma Ltd stocks regularly to stay informed about significant price changes and assess the stock's performance over time, which will help them identify trends and make timely decisions.

How can an investor assess the risk of buying Piramal Pharma Ltd stock at their 52-week low?

An investor can analyze the reasons for the Piramal Pharma Ltd stock price drop, evaluate the company’s fundamentals, and consider market conditions. Investors should also review the stock’s historical performance and any potential recovery indicators.

Should investors consider the overall market trend when evaluating Piramal Pharma Ltd stocks at their 52-week low?

Certainly, considering the overall market trend when evaluating Piramal Pharma Ltd stocks at their 52-week low is significant as it provides context for the stock’s performance and potential future movements. A declining market trend may influence Piramal Pharma Ltd stock performance, impacting the timing and potential of the investment.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*